← Back to patent-cliff list

CAS 75-12-7

Amide c1formamide

Codes: (II)461018-8-a,(II)461018-8-b, (XI)461018-22-a, (IX)461018-25-a, (VI)461018-27-a, (IV)461018-29-a, PLIN-007

Application context (from source-drug indications)

Waldenström macroglobulinaemiaIbrutinibChronic lymphocytic leukaemiaIbrutinibMantle cell lymphomaIbrutinibGraft-versus-host diseaseIbrutinibNon-small cell lung cancerPlinabulinNeutropeniaPlinabulinMultiple myelomaPlinabulinLung cancerPlinabulinSmall cell lung cancerPlinabulinMerkel细胞癌Plinabulin

Source drugs (routes using this intermediate)

DrugTierExpiry
IbrutinibTier A — Act now2027
PlinabulinTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.